Antimicrobial resistance (AMR) poses a serious global health threat, compromising routine medical procedures and reversing advances in modern medicine by making antimicrobials ineffective against infections. The inappropriate use of antimicrobials is a major driver of AMR, while many resource-limited settings still struggle with inadequate access to essential, quality-assured medicines.
National and global surveillance data on antimicrobial use (AMU) are vital for guiding stewardship and monitoring progress towards better access to and use of antimicrobials. In 2020, WHO integrated the global programme on surveillance of AMU into the Global Antimicrobial Resistance and Use Surveillance System (GLASS), with an increasing number of Countries, Territories, and Areas (CTAs) enrolling and reporting their national AMU data.
This webinar marked the launch of the “Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: Antibiotic Use Data for 2022”.
Agenda:
- Opening remarks: Yvan Hutin (Director of the Surveillance, Prevention and Control (SPC) Department, Antimicrobial Resistance (AMR) Division)
- Overview and introduction to the Global Antimicrobial Resistance and Use Surveillance System – Antimicrobial Use: Verica Ivanovska and Arno Muller (WHO AMR Division, SPC Department)
- GLASS report: antibiotic use data for 2022 - Key Findings: Martina Escher (WHO AMR Division, SPC Department)
- Using national AMU data to Inform national policies: example from Nepal: Kiran Sunder Bajracharya (Nepal Ministry of Health and Population)
- A perspective from the World Medical Association on enhancing responsible prescribing: Yassen Tcholakov (World Medical Association)
- Questions and answers (Q&A)
- Way forward and conclusion: Benedikt Huttner (WHO AMR Division, SPC Department)
The session was moderated by Zlatina Dobreva (WHO AMR Division, SPC Department).
French and Spanish interpretation was available.